ARTICLE | Distillery Therapeutics
RNA editing of MECP2 for Rett syndrome
October 4, 2022 11:48 PM UTC
RNA editing to restore normal expression of the mutated transcription factor MECP2 could help treat Rett syndrome. The RNA editor consisted of an AAV expressing an engineered hyperactive catalytic ADA...
BCIQ Target Profiles